The world leader in beauty is gaining momentum in promising segments. It will invest €60 million in increasing the capacity of its perfume factory in Gauchy (Picardy) and will also increase its stake in the Swiss dermatology group Galderma by 20%.
L’Oréal is focusing on perfumes and dermatology.
The world leader in beauty has announced a €60 million investment in its perfume factory in Gauchy, in the Aisne region, and an increase in its stake in the Swiss group Galderma. Its stake will increase from 10% to 20% in what it describes as the “world leader exclusively dedicated to dermatology, present in around 90 countries,” with “a premium portfolio of innovative brands and services derived from scientific research covering a broad spectrum of the fast-growing dermatology market.”
€60 million in its perfume factory in Gauchy
On the fragrance side, following the example of its American competitor Estée Lauder, which has just inaugurated its Maison des Parfums in Paris, a new innovation center using the latest technologies to create new fragrances, L’Oréal has fully understood the message of the boom in this segment. According to a recent study by Bain & Company, within a stable luxury and beauty market in 2025, luxury perfumes remain a dynamic category. And they are expected to experience another rebound in 2026.
Discover our plans Subscribe for 1€ Become an active member of the community of luxury leaders.
Read also > Kering set to sell its Beauty division to L’Oréal
Featured photo: © Alain Buu/Wilmotte & Associés
